Virginia Cancer Institute — Richmond, Virginia

Public research footprint of Virginia Cancer Institute, compiled from the ClinicalTrials.gov public registry.

211

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Locally Advanced Urothelial Carcinoma · Anatomic Stage III Breast Cancer AJCC v8

Recently updated registry entries

NCT07492641 — BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… (Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Virginia Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.